synimmune.de
SYNIMMUNE GmbH: WelcomeSYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of.
http://www.synimmune.de/
SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of.
http://www.synimmune.de/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
1.4 seconds
16x16
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
6
SITE IP
185.15.195.231
LOAD TIME
1.425 sec
SCORE
6.2
SYNIMMUNE GmbH: Welcome | synimmune.de Reviews
https://synimmune.de
SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of.
synimmune.de
SYNIMMUNE GmbH: Meet SYNIMMUNE
http://www.synimmune.de/news-media/meet-synimmune
32;» News and Media. 32;» Meet SYNIMMUNE. November 7-9, 2016 in Cologne, Germany. Dr Steiner will attend the BIO-Europe in Cologne, Germany.
SYNIMMUNE GmbH: Sitemap
http://www.synimmune.de/special-pages/sitemap
32;» Sitemap.
SYNIMMUNE GmbH: Publications
http://www.synimmune.de/news-media/publications
32;» News and Media. 32;» Publications. Characterization of a bispecific FLT3 X CD3 antibody in an improved, recombinant format for the treatment of leukemia. Schmiedel D, Hofmann M. Vogt F, Nübling T, Pyz E, Bühring HJ, Rammensee HG. Salih HR, Grosse-Hovest L. Mol Ther. 2015 Jan. A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells. Otz T, Grosse-Hovest L. Hofmann M, Rammensee HG. Leukemia. 2009 Jan. Brem G, Jung G.
SYNIMMUNE GmbH: Imprint
http://www.synimmune.de/special-pages/imprint
32;» Imprint. Geschäftsführer im Sinne des GmbHG):. Dr Martin Steiner, Dr. Ludger Große-Hovest. HRB 734603, Amtsgericht Stuttgart. VAT No.: DE274429902. Responsible for the content of the SYNIMMUNE GmbH web-pages according to 6 MDStV: Dr. Martin Steiner and Dr. Ludger Große-Hovest. Links to third party information.
SYNIMMUNE GmbH: Articles about SYNIMMUNE
http://www.synimmune.de/news-media/articles-about-synimmune
32;» News and Media. 32;» Articles about SYNIMMUNE. Articles about SYNIMMUNE GmbH. 15032012, Schwäbisches Tagblatt. Antikörper für erste Krebsstudie. Erhält 2,7 Millionen Euro Fördermittel. Antikörper zur Therapie bei Leukämie hat die Firma Synimmune. Entwickelt. Jetzt beginnt sie mit der Produktion dieser Antikörper für eine erste klinische Studie. Möglich wird das durch eine Förderung vom Bund in Höhe von 2,7 Millionen Euro. 032011, www.wirtschaft-neckar-alb.de. 01022011, www.biotechnologie.de.
TOTAL PAGES IN THIS WEBSITE
11
Hover
Http:/ www.theweathernetwork . Http:/ www.imdb.com. Hover lets you easily create simple ways to access your digital life.
Synimed Spine
Synimed VET :: coming soon ::
We're working on our new site, please check back soon. Any inquiries please contact us at spierce@synimedvet.com.
synimic (Scout Smith) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 4 Years. This deviant's full pageview. Last Visit: 12 weeks ago. This is the place where you can personalize your profile! Pirates ...
SYNIMMUNE GmbH: Welcome
32;» Welcome. SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of hematopoietic and solid malignancies. The company was founded in 2010 as a spin-off of the Department of Immunology at the University of Tübingen, which is headed by Prof. Dr. Hans-Georg Rammensee. SYNIMMUNE congratulates Hans-Georg Rammensee. For receiving the Award of the Deutsche Krebshilfe (German Cancer Aid Award). Auf der Morgenstelle 15.
SYNIMMUNE GmbH: Welcome
32;» Welcome. SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of hematopoietic and solid malignancies. The company was founded in 2010 as a spin-off of the Department of Immunology at the University of Tübingen, which is headed by Prof. Dr. Hans-Georg Rammensee. SYNIMMUNE congratulates Hans-Georg Rammensee. For receiving the Award of the Deutsche Krebshilfe (German Cancer Aid Award). Auf der Morgenstelle 15.
Synin - Pharmaceutical and Healthcare Market Research App
Synergy Logistics
Export / Import Solutions. Powered by InstantPage® from GoDaddy.com. Want one?
Synindltd.com
S.Y.N INDUSTRY Co,Ltd
SYN INDUSTRY Co,Ltd. รับผลิตกล่องกระดาษ แกนกระดาษ ปลอกกระดาษสวมแก้วกาแฟ cup sleeve ทิชชูพิมพ์โลโก้ จานรองแก้วกระดาษอัดชานอ้อย. เกี่ยวกับเรา. กล่องกระดาษลูกฟูก. จานรองแก้วกระดาษอัดชานอ้อย. เกี่ยวกับเรา. บริษัท เอส.วาย.เอ็น อินดัสตรี จำกัด. เป็นโรงงานผลิตและจำหน่าย กล่องกระดาษ แกนกระดาษ จานรองแก้วกระดาษอัดชานอ้อย กระดาษสวมแก้วกาแฟ (cup sleeve ) ปลอกกาแฟ (coffee sleeve). 1 กล่องกระดาษลูกฟูก 3 ชั้น 5 ชั้น. 3 กระดาษสวมแก้วกาแฟ (cup sleeve ) ขนาด 22 ออนซ์ 16 ออนซ์ 8 ออนซ์. 4 ถ้วยกระดาษพิมพ์ลาย.
